Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from the Roy Castle Lung Cancer Foundation

Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from the Roy Castle Lung Cancer Foundation

Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from the Roy Castle Lung Cancer Foundation
10 March 2011
(65.3 Kb 19 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 08 March 2011